Posts tagged ‘hydrogenated fats’
Recently, KV Pharmaceutical of suburban St.Louis won government approval to exclusively sell a pregnancy drug, known as Makena. Makena is a synthetic form of the hormone progesterone commonly given to women who are at risk of preterm births. The March of Dimes and many obstetricians initially supported the approval because they thought it would mean that the quality would be more consistent and it would be easier to get. Plus, the drug has only been about $10 to $20 per injection, so it comes relatively cheap. Starting this week, they’ll be surprise to see two more zeros attached to the price tag of each injection – the price of Makena shoots up to $1,500 a dose. KV Pharmaceutical is taking nice advantage of their exclusive ownership of the drug. (more…)
The scientists at Hasbro are hard at work redesigning the classic Easy-Bake Oven. In early 2012, the 100-watt incandescent light bulb will no longer be available. So Hasbro is coming out with the Easy Bake Ultimate Oven which will feature “a heating element that does not use a light bulb and offers an extensive assortment of mixes reflective of the hottest baking trends for today,” according to Hasbro’s statement. (more…)
1) The Food and Drug Administration’s panel of respiratory device experts recently voted that Asthmatx’s Alair System be approved under certain conditions, including long-term safety monitoring of patients. The company’s procedure, called bronchial thermoplasty, uses extreme heat to burn away lung tissue that makes it difficult to breath and causes coughing spasms and wheezing. Asthma medications were among the top-selling drugs in the U.S. last year. ** I think the company should change their slogan “It’s about breathing” to “It’s about breathing and burning your lung tissue”. More catchy. Most don’t realize that asthma is as much, or sometimes more, of an adrenal gland problem as it is a lung problem. I’ve written two articles about this subject, here and here.
2) Today a cat in Iowa was found to be infected with the swine flu. **The news here is not that it is first time the virus has been known to cross over to a dog or cat, but who the heck actually goes and gets their pet tested for H1N1? (more…)
February 18, 2005 was an important day for drug makers, namely Merck and Pfizer, as the decision to keep their Cox-2 inhibitor drugs on the market looks ever so promising. Advisory groups to the Food and Drug Administration have recommended that the benefits of the Cox-2 inhibitors, (Vioxx, Celebrex, and Bextra), outweigh the risks. This in turn sent Merck, (maker of Vioxx), and Pfizer, (maker of Celebrex and Bextra), stock shares up 13 and 7 percent respectively. Not bad for a one day return in the bank. Now let’s consider the health returns.
Cox-1 and Cox-2 inhibitors selectively block an enzyme that is responsible for inflammation. They are a type of nonsteroidal anti-inflammatory drugs (NSAIDs) because these medications essentially fight inflammation. Drugs such as aspirin and ibuprofen and to some extent diclofenac, block both the Cox-2 and Cox-1 enzymes while other such as Vioxx and Celebrex block just the Cox-2. The reason so many doctors like the heavy duty Cox-2 meds is because they do not block the Cox-1 enzyme, which helps the stomach make a beneficial prostaglandin (a hormone-like chemical messenger), to protect the stomach lining. This is why NSAIDs often times cause stomach and gastrointestinal ulcerations. However, like all medications, there are risks and side effects. And in the Fall of 2004 when news resurfaced that the Cox-2 inhibitor Vioxx was responsible for cardiovascular problems such as heart attacks, turmoil erupted and it was pulled from the shelves. Merck’s stock plummeted and medical doctors threw up their arms as they knew no other way to get their patients out of pain other than revert back to the NSAIDs. I covered this in November 2004. We have now gone full circle, so ironically enough it is a good place to pick up again here in 2005. (more…)